fluconazole has been researched along with Trichomonas Vaginitis in 5 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Trichomonas Vaginitis: Inflammation of the vagina, marked by a purulent discharge. This disease is caused by the protozoan TRICHOMONAS VAGINALIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The primary end points were bacterial vaginosis (BV), vaginal candidiasis, trichomoniasis vaginalis (hereafter, "trichomoniasis"), and colonization with Lactobacillus organisms." | 2.73 | Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. ( Baeten, JM; Chohan, V; Hassan, WM; Holmes, KK; Jaoko, W; Kiarie, J; Kurth, AE; Lavreys, L; Mandaliya, K; McClelland, RS; Ndinya-Achola, JO; Richardson, BA, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mochache, V | 1 |
| McClelland, RS | 2 |
| Balkus, JE | 1 |
| Ressel, GW | 1 |
| Buscemi, L | 1 |
| Arechavala, A | 1 |
| Negroni, R | 1 |
| Villagrana-Zesati, R | 1 |
| Reyna-Figueroa, J | 1 |
| Ortiz-Ibarra, J | 1 |
| Richardson, BA | 1 |
| Hassan, WM | 1 |
| Chohan, V | 1 |
| Lavreys, L | 1 |
| Mandaliya, K | 1 |
| Kiarie, J | 1 |
| Jaoko, W | 1 |
| Ndinya-Achola, JO | 1 |
| Baeten, JM | 1 |
| Kurth, AE | 1 |
| Holmes, KK | 1 |
2 trials available for fluconazole and Trichomonas Vaginitis
| Article | Year |
|---|---|
Short-term therapy for mixed vaginal infections.
Topics: Administration, Oral; Antifungal Agents; Antiprotozoal Agents; Antitrichomonal Agents; Candidiasis, | 2006 |
Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.
Topics: Adolescent; Adult; Anti-Infective Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluc | 2008 |
3 other studies available for fluconazole and Trichomonas Vaginitis
| Article | Year |
|---|---|
Periodic presumptive treatment for women with prevalent vaginal infections: secondary analysis of data from a randomized controlled trial.
Topics: Adult; Anti-Infective Agents; Candidiasis, Vulvovaginal; Chemoprevention; Female; Fluconazole; Human | 2014 |
CDC releases 2002 guidelines for treating STDs: Part I. Diseases characterized by vaginal discharge and PID.
Topics: Anti-Infective Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Metronidazole; Pelvic | 2002 |
[Study of acute vulvovaginitis in sexually active adult women, with special reference to candidosis, in patients of the Francisco J. Muñiz Infectious Diseases Hospital].
Topics: Acute Disease; Adolescent; Adult; Argentina; Candida; Candidiasis, Vulvovaginal; Carrier State; Como | 2004 |